Present and future of FDG-PET/CT in ovarian cancer

Ann Nucl Med. 2011 Apr;25(3):155-64. doi: 10.1007/s12149-010-0449-8. Epub 2010 Nov 27.


Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

Publication types

  • Review

MeSH terms

  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Neoplasm Staging
  • Ovarian Neoplasms / diagnostic imaging*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy
  • Positron-Emission Tomography / methods*
  • Positron-Emission Tomography / trends*
  • Tomography, X-Ray Computed / methods*
  • Tomography, X-Ray Computed / trends*
  • Treatment Outcome


  • Fluorodeoxyglucose F18